오소바이오로직스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Orthobiologics Market size is expected to reach USD 13.96 Billion in 2034 from USD 8.11 Billion (2025) growing at a CAGR of 6.21% during 2026-2034.

The orthobiologics market is experiencing rapid development as regenerative medicine becomes central to musculoskeletal treatments. Derived from natural substances such as bone grafts, platelet-rich plasma, and stem cell therapies, orthobiologics are being increasingly utilized to accelerate healing, enhance tissue regeneration, and reduce recovery times in orthopedic procedures. Rising incidences of sports injuries, osteoarthritis, and trauma-related conditions are fueling demand for these advanced therapies.

Future growth will be driven by breakthroughs in biomaterials, 3D printing, and bioengineered scaffolds that improve integration and long-term functionality. Research pipelines are focusing on next-generation orthobiologics with higher bioactivity and controlled release mechanisms, ensuring more effective outcomes. The integration of orthobiologics with minimally invasive surgical techniques is expected to enhance procedural efficiency, reduce complications, and expand adoption across orthopedic centers globally.

The market outlook is strengthened by increasing investments in clinical trials and regulatory support for innovative therapies. Personalized medicine approaches, such as patient-specific grafts and tailored cellular therapies, are shaping the future landscape. With rising healthcare expenditures and growing awareness of regenerative solutions, the orthobiologics market is positioned to evolve as a cornerstone of advanced orthopedic care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Demineralized Bone Matrix (DBM)
• Hydroxyapatite (HAp)
• Hyaluronic acid (HA)
• Calcium Sulfate Matrix
• AZA2-tricalcium phosphate (AZA2-TCP)
• AZA2-TCP + HAp
• DBM + HA
• AZA2-TCP + PLGA
• Regenerative medicine
• Growth Factors

By End-user

• Hospitals
• Orthopedic Clinics
• Others (ENT Clinics, etc.)

COMPANIES PROFILED

• Arthrex Inc, ATEC Spine Inc, Bioventus, Exactech Inc, Globus Medical, Integra Lifesciences Corporation, Johnson Johnson, Medtronic plc, MTF Biologics, NORAKER, RTI Surgical, Stryker, Zimmer Biomet
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORTHOBIOLOGICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Demineralized Bone Matrix (DBM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hydroxyapatite (HAp) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hyaluronic acid (HA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Calcium Sulfate Matrix Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. AZA2-tricalcium phosphate (AZA2-TCP) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. AZA2-TCP + HAp Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. DBM + HA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. AZA2-TCP + PLGA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Regenerative medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Growth Factors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORTHOBIOLOGICS MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Orthopedic Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others (ENT Clinics, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORTHOBIOLOGICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ORTHOBIOLOGICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Arthrex Inc
  • 8.2.2 ATEC Spine Inc
  • 8.2.3 Bioventus
  • 8.2.4 Exactech Inc
  • 8.2.5 Globus Medical
  • 8.2.6 Integra Lifesciences Corporation
  • 8.2.7 Johnson & Johnson
  • 8.2.8 Medtronic Plc
  • 8.2.9 MTF Biologics
  • 8.2.10 NORAKER
  • 8.2.11 RTI Surgical
  • 8.2.12 Stryker
  • 8.2.13 Zimmer Biomet